Envoy Medical Inc. (NASDAQ: COCH) announced the grant of two international patents, bringing its total global patent portfolio to 97, comprising 40 U.S. and 57 foreign patents. The company also holds 35 pending applications, including 26 foreign and 9 U.S., according to a press release.

The Canadian Patent Office granted Canadian Patent No. 3,130,978, titled "Implantable Cochlear System with Integrated Components and Lead Characterization." The patent covers technology related to characterizing electrical conductors within an implantable cochlear system.

The Hong Kong Patent Office granted Hong Kong Patent No. HK40108431, titled "Implantable Cochlear System and Corresponding Method of Compensating for Variability in a Middle Ear Sensor." The patent covers systems and methods for compensating for variability in a middle ear sensor, including techniques for processing and normalizing signals received from the sensor.

Brent Lucas, Chief Executive Officer of Envoy Medical, said in the statement: "While each patent has its place, the sum of our overall strategy is much more valuable than the individual parts. Combining our intellectual property with the courage to put forward different architectures is what will ultimately set us apart for years to come."

The company, based in White Bear Lake, Minnesota, develops fully implanted hearing devices. Its portfolio spans technologies related to sensing, signal processing, implantation, and system integration for its fully implanted hearing platform.